×
ADVERTISEMENT

RealTime IDH2 Assay

FDA Approves Idhifa and RealTime IDH2 Assay for Relapsed or Refractory AML

Celgene's Idhifa was approved to treat adult patients with relapsed or refractory AML who have a specific genetic ...

AUGUST 2, 2017

Load more